Objects
Zdenkowski, N., Butow, P., Mann, G. B., Fewster, S., Beckmore, C., Isaacs, R., Douglas, C., Boyle, F. M.. Wiley-Blackwell Publishing; 2016. A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.
McCarthy, N., Boyle, F., Gebski, V., Veillard, A. S., Zannino, D., Wilcken, N., Reaby, L., Lindsay, D. F., Badger, H. D., Forbes, J. F., Zdenkowski, N., Bull, J., Leong, E., Simpson, A., Kannourakis, G., Francis, P. A., Chirgwin, J., Abdi, E.. Elsevier; 2014. Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem).
Zdenkowski, N., Cavenagh, J., Ku, Y. C., Bisquera, A., Bonaventura, A.. Wiley-Blackwell Publishing Asia; 2013. Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy.
Jansen, J., Serafimovska, A., Glassey, R., Zdenkowski, N., Saunders, C., Porter, D., Butow, P.. Elsevier; 2021. The implementation of a decision aid for women with early-stage breast cancer considering contralateral prophylactic mastectomy: A pilot study.
Zdenkowski, N., Forbes, J. F., Mann, G. B., Coates, A. S., Gebski, V., Davies, L., Thornton, R., Reaby, L., Cuzick, J., Green, M., Boyle, F. M., Kannourakis, G., Gill, P. G., Bayliss, E., Saunders, C., Della-Fiorentina, S., Kling, N., Campbell, I.. Oxford University Press; 2016. Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.
Ackland, Stephen P., Gebski, V., Forbes, J. F., Coates, A. S., , Zdenkowski, N., Wilson, A., Green, M., Tees, S., Dhillon, H., Van Hazel, G., Levi, J., Simes, R. J.. Springer; 2019. Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311.